Anteris Technologies Global (ASX:AVR) Beneish M-Score: -3.92 (As of Jun. 24, 2026)


ASX:AVR Anteris Technologies Global Corp ASX:AVR
50 GF Score
Price A$15.00
! 7 Warning Signs
View Full Analysis

What is Anteris Technologies Global Beneish M-Score?

Anteris Technologies Global ASX:AVR +10.05% 50 Beneish M-Score is -3.92 as of Jun. 24, 2026. GuruFocus rates ASX:AVR with a GF Score™ of 50/100. The stock has 7 warning signs investors should review. Among 765 Medical Devices & Instruments companies, Anteris Technologies Global ranks better than 93.07% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.92 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Anteris Technologies Global's Beneish M-Score or its related term are showing as below:

ASX:AVR' s Beneish M-Score Range Over the Past 10 Years
Min: -8.05   Med: -3.92   Max: -3.86
Current: -3.92

During the past 13 years, the highest Beneish M-Score of Anteris Technologies Global was -3.86. The lowest was -8.05. And the median was -3.92.

Anteris Technologies Global Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Anteris Technologies Global's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anteris Technologies Global Beneish M-Score Chart

Anteris Technologies Global Annual Data
Trend Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -8.05

Anteris Technologies Global Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -3.86 0.00 -8.05 -3.92

ASX:AVR vs INMD, QDEL, SSII: Beneish M-Score Comparison

For the Medical Devices subindustry, Anteris Technologies Global's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anteris Technologies Global Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Anteris Technologies Global's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Anteris Technologies Global's Beneish M-Score falls into.


ASX:AVR
50GF Score
Anteris Technologies Global Corp ASX:AVR
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anteris Technologies Global Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Anteris Technologies Global for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.162+0.528 * 0.7185+0.404 * 0.1474+0.892 * 0.7259+0.115 * 1.1599
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.3388+4.679 * -0.041588-0.327 * 0.2145
=-3.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was A$0.33 Mil.
Revenue was 0.704 + 0.467 + 0.65 + 0.949 = A$2.77 Mil.
Gross Profit was 0.541 + 0.33 + 0.464 + 0.722 = A$2.06 Mil.
Total Current Assets was A$408.50 Mil.
Total Assets was A$419.98 Mil.
Property, Plant and Equipment(Net PPE) was A$11.33 Mil.
Depreciation, Depletion and Amortization(DDA) was A$2.52 Mil.
Selling, General, & Admin. Expense(SGA) was A$40.86 Mil.
Total Current Liabilities was A$19.51 Mil.
Long-Term Debt & Capital Lease Obligation was A$3.45 Mil.
Net Income was -32.809 + -43.949 + -33.722 + -32.001 = A$-142.48 Mil.
Non Operating Income was 2.32 + -0.775 + 0.108 + -0.24 = A$1.41 Mil.
Cash Flow from Operations was -40.869 + -27.883 + -27.67 + -30.006 = A$-126.43 Mil.
 Total Receivables was A$2.80 Mil.
Revenue was 0.882 + 0.846 + 1.136 + 0.952 = A$3.82 Mil.
Gross Profit was 0.554 + 0.518 + 0.482 + 0.482 = A$2.04 Mil.
Total Current Assets was A$84.08 Mil.
Total Assets was A$93.30 Mil.
Property, Plant and Equipment(Net PPE) was A$9.00 Mil.
Depreciation, Depletion and Amortization(DDA) was A$2.41 Mil.
Selling, General, & Admin. Expense(SGA) was A$42.05 Mil.
Total Current Liabilities was A$22.89 Mil.
Long-Term Debt & Capital Lease Obligation was A$0.90 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.329 / 2.77) / (2.798 / 3.816)
=0.118773 / 0.733229
=0.162

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(2.036 / 3.816) / (2.057 / 2.77)
=0.533543 / 0.742599
=0.7185

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (408.503 + 11.326) / 419.979) / (1 - (84.082 + 8.995) / 93.303)
=0.000357 / 0.002422
=0.1474

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2.77 / 3.816
=0.7259

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(2.409 / (2.409 + 8.995)) / (2.522 / (2.522 + 11.326))
=0.211242 / 0.18212
=1.1599

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(40.864 / 2.77) / (42.05 / 3.816)
=14.752347 / 11.019392
=1.3388

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((3.454 + 19.514) / 419.979) / ((0.897 + 22.892) / 93.303)
=0.054688 / 0.254965
=0.2145

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-142.481 - 1.413 - -126.428) / 419.979
=-0.041588

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Anteris Technologies Global has a M-score of -3.97 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -3.92 mean?
Anteris Technologies Global (ASX:AVR) has a Beneish M-Score of -3.92 as of Jun. 24, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Anteris Technologies Global and its competitors. According to the industry distribution chart, Anteris Technologies Global ranks #53 out of 765 companies in the Medical Devices & Instruments industry, placing it in the top 6.9%.
Is Anteris Technologies Global's Beneish M-Score too high?
Anteris Technologies Global's current Beneish M-Score is -3.92. Based on the distribution chart, Anteris Technologies Global ranks #53 out of 765 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Anteris Technologies Global has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Anteris Technologies Global's Beneish M-Score compare to INMD and QDEL?
According to the Medical Devices & Instruments industry distribution chart, Anteris Technologies Global ranks #53 out of 765 companies for Beneish M-Score. This places Anteris Technologies Global in the top 7% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Anteris Technologies Global and its competitors. Anteris Technologies Global's current Beneish M-Score is -3.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anteris Technologies Global stock overvalued right now?
Anteris Technologies Global (ASX:AVR) has a current Beneish M-Score of -3.92. The current Beneish M-Score is -3.92. Anteris Technologies Global's overall GF Score™ is 50/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Anteris Technologies Global (ASX:AVR), the current Beneish M-Score is -3.92 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anteris Technologies Global Business Description

Other Exchanges AVR:USA
Address 9 Sherwood Road, Level 3, Suite 302, Toowong Tower, Toowong, QLD, AUS, 4066
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.
50GF Score

Get the complete analysis for ASX:AVR

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$15.00
Price